Lifshitz A, Carlos Manuel Ortíz-Mendoza CM

Language: Spanish
References: 26
Page: 97-100
PDF size: 58.78 Kb.

Text Extraction

No abstract

REFERENCES

1. Curiel-Valdés JJ. Citología vaginal: la importancia de la zona de transformación y cómo obtener una muestra adecuada Gac Med Mex:2002;138:259-65.

2. Rimer BK, Schildkraut J, Hiatt RA. Cancer screening. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors: cancer. Principles and practice of oncology. 6th. edition Lippincot Williams and Wilkins 2001:627-40.

3. World Health Organization Control of cancer of the cervix uteri. Bull WHO 1986;64:607-618.

4. Fahey MT, Irwig L, MacCaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.

5. Spitzer M. Cervical screening adjuncts: recent advances. Am J Obstet Gynecol 1998;179:544-56.

6. Lazcano-Ponce E, Alonso de Ruiz P, López CL Hernández AM. Quality control study on negative gynecological citology in Mexico. Diag Cytopathol 1994;10:l0-14.

7. Eluf-Neto J, Ramalho NCM. Cervical cancer in Latin America Semin Oncol 2001;28:188-97.

8. Papanicolaou G, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol 1941;42:193-206. Reimpreso: Arch Pathol Lib Med 1997;121: 211-24.

9. Arzac JP. Valor de la citología de descamación vaginal en el diagnóstico de la fisiología ovárica y del cáncer uterino. Ginec Obst Mex 1946;2:107-16. Reimpreso: Ginec Obst Mex 2001;69:453-60.

10. Téllez-Márquez A. Citología cervicovaginal. Rev Mex Patol Clin 2000;47:117-9.

11. Montes-Sánchez G, Sierra-López L, Mejía-Mejía J, Camona-González E. Eficacia del cepillo cervical en obtención de muestra endocervical en comparación con el abatelenguas. Ginec Obst Mex 1997;65:305-9.

12. Olivas-Mendoza G, Aldana-Bustamante A, Delgado-Morales M, Gándara-Acosta V. Citología cervical: hallazgos dependientes del biocolector. Ginec Obst Mex: 1997;65:515-9.

13. Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA 1989;261:737-43.

14. Institute for clinical system integration. Cervical cancer screening. Postgrad Med 1997;102:185-94.

15. Sawaya GF, Brown AD, Washington AE, Garber AM. Current approaches to cervical cancer screening. N Engl J Med 2001;344:1603-7.

16. Canadian Society of Cytology. The adequacy of the Papanicolaou smear. CMAJ 1994;150:25-6.

17. Martin-Hirsch P, Lilford R, Jarvis G, Kitchener. Efficacy of cervical-smear collection devices: a systematic review and meta-analysis. Lancet 1999;354:1763-70.

18. Stack PS. Pap smears: still a reliable screening tool for cervical cancer. Postgrad Med 1997;101:207-14.

19. Grohs DH. Challenges in cervical cancer screening: what clinicians, patients and the general public need to known. Acta Cytol 1996;40:133-7.

20. McGoogan E, Colgan TJ, Ramzy I y cols. Cell preparation methods and eriteria for sample adequacy: IAC task force summary. Acta Cytol 1998;42:25-32.

21. Woodman CBJ, Yates M, Ward K y cols. Indicators of effective cytological sampling of the uterine cervix. Lancet1989;2:88-90.

22. Austin RM, McLendon WW. The Papanicolaou smear: medicine’s most successful cancer screening procedure is threatened JAMA 1997;277:75-5.

23. Greer BE. The gynecologist’s perspective of liability and quality issues with the Papanicolaou smear. Arch Pathol Lib Med 1997;121:246-9.

24. Cannistra S, Niloff JM. Cancer of the uterine cervix. N Engl J Med 1996;334:1030-8.

25. Arillo-Santillán E, Lazcano-Ponce E, Peric M y cols. El conocimiento de profesionales de la salud sobre la prevención del cáncer cervical: alternativas de educación médica. Salud Pub Mex 2000;42:34-42.

26. De la Garza JG, Ramírez LJ, Solorza G, Juárez P, Aguilar JL, Mota A. Cáncer cérvico-uterino. Gac Méd Méx 2000;136 (Supl 3):s65-8.